Investegate |Jersey Oil & Gas PLC Announcements | Jersey Oil & Gas PLC: Result of AGM
Investegate announcements from Jersey Oil & Gas PLC, Result of AGM
Stay updated with breaking news from Benjamin Cryer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Jersey Oil & Gas PLC, Result of AGM
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...
("Jersey Oil & Gas", "JOG" or the "Company") Jersey Oil & Gas (AIM:JOG), an independent upstream oil and gas company focused on the UK Continental Shelf region of the North Sea, announces that it will today post to shareholders copies of its Annual Report and Accounts for the year ended 31 December 2020 together with the Notice of Annual General Meeting ("AGM") and Form of Proxy. An electronic copy of these documents will also be made available on the Company's website ( www.jerseyoilandgas.com ). The AGM will be h...
and The Board of SEC Newgate (AIM: SECN), the insight-driven global strategic communications group that works at the nexus of business, politics, communities, markets and media, is pleased to provide an update on results (unaudited) for the year ended 31 December 2020. · Gross Profit of €56.1m (2019: €37.6m) · Profit before Tax of €3.0m (2019: €1.3m) · Group net Debt (at 31 December 2020) of €7.4m (excluding the impact of c. €5.6 million IFRS 16 adjustments for leases) (2019: €8.7m (excl...
Open Orphan plc (London and Euronext: ORPH) is a rapidly growing pharmaceutical service/contract research company that is a world leader in testing vaccines and antivirals using human challenge clinical trials. The company provides services to Big Pharma, biotech and government/public health organisations. Open Orphan runs challenge studies in London from both its 19-bedroom Whitechapel quarantine clinic, opened in February 2021, and its 24-bedroom QMB clinic which also has a highly specialised virology and immunology laboratory on-site. Open Orphan has a le...